E-MOTIVE
EAGLE
EAGLE-1
EAGLE-2
EAGLE-3
Early High Protein in Critical Illness
Early liver transplantation for severe alcoholic hepatitis
Early mobilization in the ICU
Early MRI for low back pain
Early palliative care for metastatic NSLC
Early SSC for Preterm Neonates
EARLY TAVR
Early TIPS for variceal hemorrhage
EARLY-SIMPLIFIED
EARLY-UNLOAD
EARLYDRAIN
EARNEST
EASE
EAST-AFNET 4
EAT-ICU
EBC MAIN
ECASS III
ECHELON-1
ECHOGUIDE
EchoPAIN
ECLA PHRI COLCOVID
ECLS-SHOCK (1-year follow-up)
ECLS-SHOCK (original research)
ECOSPOR III
ECOSPOR III (post-hoc analysis)
ECST
EFFAMPART
EFFECT (electronic cigarettes vs. placebo)
EFFECT (electronic cigarettes vs. varenicline)
Effect of Screen Time on Recovery From Concussion
EFFECTS
eHealth intervention on Anxiety for AAA
EHR Nudge
EID LIFE
EINSTEIN-PE
EIRPI
ELAIN
ELAIN FOLLOW-UP
ELAN
ELATIVE
ELDERCARE-AF (subanalysis)
ELEKT-D
ELEVATE
ELIXA
EMBARK
EMBARK (enzalutamide monotherapy)
EMBARK (enzalutamide plus leuprolide)
EMBER-3 (imlunestrant)
EMBER-3 (imlunestrant/abemaciclib)
EMBOLISE
EMBRACA
EMBRACE (ambulatory ECG monitoring)
EMBRACE (azithromycin)
EMERALD
EMERGE
EMERGENT-1
EMERGENT-3
EMILIA
EMMA
EMPA-HEART2 CardioLink-7
EMPA-KIDNEY
EMPA-KIDNEY (long-term follow-up)
EMPA-REG OUTCOME
EMPACT-MI
EMPACTA
EMPEROR-Preserved
EMPEROR-Reduced
EMPHASIS-HF
EMPROTECT
EMPULSE
ENGAGE AF-TIMI 48 (edoxaban 30 mg)
ENGAGE AF-TIMI 48 (edoxaban 60 mg)
ENGAGE AF-TIMI 48 (post-hoc analysis, edoxaban 60 mg vs. 30 mg)
ENGAGE AF-TIMI 48 (post-hoc analysis, edoxaban vs. warfarin)
ENGAGES-CANADA
ENHANCE-1
ENHANCE-2
ENRICH
ENTRUST-AF PCI
ENVISAGE-TAVI AF
ENVISION
ENZAMET
EOLIA
EORTC-62092 STRASS
EPaNIC (2-year follow-up)
EPaNIC (original research)
EPCAT I
EPCAT II
EPHESUS
EPIC-CAD
EPIC-HR
EPICC
EPIPAN
EPO-TBI (6-month outcomes)
EPO-TBI (long-term follow-up)
EPVent2
ERADICATE
Erenumab for Medication Overuse Headache (140 mg)
Erenumab for Medication Overuse Headache (70 mg)
ERSPC
ESCAPe (community-acquired pneumonia)
ESCAPE (heart failure)
ESCAPE-MeVO
ESCAPE-TRD
ESCORT-NEO/NCCES01 (camrelizumab plus albumin-bound paclitaxel and cisplatin)
ESCORT-NEO/NCCES01 (camrelizumab plus paclitaxel and cisplatin)
ESETT (levetiracetam vs. fosphenytoin)
ESETT (levetiracetam vs. valproate)
ESETT (valproate vs. fosphenytoin)
ESOPEC
ESPAC4 (long-term analysis)
ESPRIT
ESSENCE
ESTxENDS
ETESRTA
EUCLID
EUPHRATES
EuRIDICE
EUROPA
European Dexamethasone Study
EVER-132-002
EVEREST-Outcomes
EVNP
Evolut low risk
EVOLVE
EVOLVED
EX-DHF
EXCEL
EXCLAIM-2
EXPECTS
EXPEDITION3
EXPLORER-HCM
explorer7
EXSCEL
EXTEND
EXTEND-IA
EXTEND-IA TNK
EXTRA
EXTRA-CVD
EXTUB-OBESE